Free Stock Market Tips with proper technical analysis and support.
Infosys
CLSA says large deal loss
puts FY17 guidance at risk after weak Q1. It may impact FY17 revenue by USD
50-100 million and FY18 revenue by USD 100-200 million. Its sya RBS deal
cancellation puts FY17 revenue guidance at risk by 0.5-1 percent. Infosys
Sun Pharma
Credit Suisse maintains outperforms
call with target unchanged at Rs 880 per share. It says guidance of 8-10
percent sales growth is still conservative.
SBI
Credit Suisse is
underweight with target increased to Rs 155 from Rs 110 per share as it feels
earnings per share (EPS) /return on equity will struggle in FY17 & FY18
given higher provisions.
Cipla
Nomura has a buy call with
increased target to Rs 605 from Rs 549 per share. It says valuations are
supported by higher earnings growth potential on low base.
Glenmark
Nomura has a buy call on
the stock with target increased to Rs 1086 from Rs 1009.
No comments:
Post a Comment